Literature DB >> 33902667

Point-of-care ultrasound of the heart and lungs in patients with respiratory failure: a pragmatic randomized controlled multicenter trial.

M Riishede1,2,3,4, A T Lassen5,6, G Baatrup7,5, P I Pietersen5,8,9, N Jacobsen5,8,9, K N Jeschke10, C B Laursen5,8.   

Abstract

BACKGROUND: Point-of-care ultrasound is a focus oriented tool for differentiating among cardiopulmonary diseases. Its value in the hands of emergency physicians, with various ultrasound experience, remains uncertain. We tested the hypothesis that, in emergency department patients with signs of respiratory failure, a point-of-care cardiopulmonary ultrasound along with standard clinical examination, performed by emergency physicians with various ultrasound experience would increase the proportion of patients with presumptive diagnoses in agreement with final diagnoses at four hours after admission compared to standard clinical examination alone.
METHODS: In this prospective multicenter superiority trial in Danish emergency departments we randomly assigned patients presenting with acute signs of respiratory failure to intervention or control in a 1:1 ratio by block randomization. Patients received point-of-care cardiopulmonary ultrasound examination within four hours from admission. Ultrasound results were unblinded for the treating emergency physician in the intervention group. Final diagnoses and treatment were determined by blinded review of the medical record after the patients´ discharge.
RESULTS: From October 9, 2015 to April 5, 2017, we randomized 218 patients and included 211 in the final analyses. At four hours we found; no change in the proportion of patients with presumptive diagnoses in agreement with final diagnoses; intervention 79·25% (95% CI 70·3-86·0), control 77·1% (95% CI 68·0-84·3), an increased proportion of appropriate treatment prescribed; intervention 79·3% (95% CI 70·3-86·0), control 65·7% (95% CI 56·0-74·3) and of patients who spent less than 1 day in hospital; intervention n = 42 (39·6%, 25·8 38·4), control n = 25 (23·8%, 16·5-33·0). No adverse events were reported.
CONCLUSIONS: Focused cardiopulmonary ultrasound added to standard clinical examination in patients with signs of respiratory failure had no impact on the diagnostic accuracy, but significantly increased the proportion of appropriate treatment prescribed and the proportion of patients who spent less than 1 day in hospital. TRIAL REGISTRATION: https://clinicaltrials.gov/ , number NCT02550184 .

Entities:  

Keywords:  Diagnostic accuracy; Emergency department; High acuity; Point–of-care ultrasound; Respiratory disease; Ultrasound

Year:  2021        PMID: 33902667     DOI: 10.1186/s13049-021-00872-8

Source DB:  PubMed          Journal:  Scand J Trauma Resusc Emerg Med        ISSN: 1757-7241            Impact factor:   2.953


  16 in total

1.  Causes of Shortness of Breath in the Acute Patient: A National Study.

Authors:  Zachariah E Hale; Astha Singhal; Renee Y Hsia
Journal:  Acad Emerg Med       Date:  2018-05-25       Impact factor: 3.451

2.  Comparison of expert and novice sonographers' performance in focused lung ultrasonography in dyspnea (FLUID) to diagnose patients with acute heart failure syndrome.

Authors:  Alan T Chiem; Connie H Chan; Douglas S Ander; Andrew N Kobylivker; William C Manson
Journal:  Acad Emerg Med       Date:  2015-04-22       Impact factor: 3.451

3.  Implementation of lung ultrasound in polyvalent intensive care unit: Impact on irradiation and medical cost.

Authors:  L Zieleskiewicz; A Cornesse; E Hammad; M Haddam; C Brun; C Vigne; B Meyssignac; A Remacle; K Chaumoitre; F Antonini; C Martin; M Leone
Journal:  Anaesth Crit Care Pain Med       Date:  2015-03-05       Impact factor: 4.132

4.  Integrated use of bedside lung ultrasound and echocardiography in acute respiratory failure: a prospective observational study in ICU.

Authors:  Benoit Bataille; Beatrice Riu; Fabrice Ferre; Pierre Etienne Moussot; Arnaud Mari; Elodie Brunel; Jean Ruiz; Michel Mora; Olivier Fourcade; Michele Genestal; Stein Silva
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

5.  Bedside Ultrasound Versus Chest Radiography for Detection of Pulmonary Edema: A Prospective Cohort Study.

Authors:  William M Wooten; Lynn E T Shaffer; Lisa A Hamilton
Journal:  J Ultrasound Med       Date:  2018-10-02       Impact factor: 2.153

6.  Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trial.

Authors:  Christian B Laursen; Erik Sloth; Annmarie Touborg Lassen; René dePont Christensen; Jess Lambrechtsen; Poul Henning Madsen; Daniel Pilsgaard Henriksen; Jesper Rømhild Davidsen; Finn Rasmussen
Journal:  Lancet Respir Med       Date:  2014-07-03       Impact factor: 30.700

7.  Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol.

Authors:  Daniel A Lichtenstein; Gilbert A Mezière
Journal:  Chest       Date:  2008-04-10       Impact factor: 9.410

8.  Evaluation of lung ultrasound for the diagnosis of pneumonia in the ED.

Authors:  Stefano Parlamento; Roberto Copetti; Stefano Di Bartolomeo
Journal:  Am J Emerg Med       Date:  2009-05       Impact factor: 2.469

9.  Focused ultrasound examination of the chest on patients admitted with acute signs of respiratory problems: a study protocol for a pragmatic randomised controlled multicentre trial.

Authors:  M Riishede; C B Laursen; L S Teglbjærg; A T Lassen; G Baatrup
Journal:  BMJ Open       Date:  2016-10-14       Impact factor: 2.692

10.  Symptom, diagnosis and mortality among respiratory emergency medical service patients.

Authors:  Tim Alex Lindskou; Laura Pilgaard; Morten Breinholt Søvsø; Torben Anders Kløjgård; Thomas Mulvad Larsen; Flemming Bøgh Jensen; Ulla Møller Weinrich; Erika Frischknecht Christensen
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

View more
  1 in total

1.  Usefulness of Multi-Organ Point-of-Care Ultrasound as a Complement to the Decision-Making Process in Internal Medicine.

Authors:  Irene Casado-López; Yale Tung-Chen; Marta Torres-Arrese; Davide Luordo-Tedesco; Arantzazu Mata-Martínez; Jose Manuel Casas-Rojo; Esther Montero-Hernández; Gonzalo García De Casasola-Sánchez
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.